Bank of America’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-118
| Closed | -$469 | – | 7504 |
|
|
2025
Q3 | $469 | Sell |
118
-26
| -18% | -$177 | ﹤0.01% | 7599 |
|
|
2025
Q2 | $1.73K | Buy |
144
+17
| +13% | +$211 | ﹤0.01% | 7452 |
|
|
2025
Q1 | $1.75K | Sell |
127
-302
| -70% | -$4.34K | ﹤0.01% | 7351 |
|
|
2024
Q4 | $6.11K | Buy |
429
+21
| +5% | +$345 | ﹤0.01% | 7066 |
|
|
2024
Q3 | $7.78K | Buy |
408
+2
| +0.5% | +$34 | ﹤0.01% | 6935 |
|
|
2024
Q2 | $7.92K | Buy |
406
+29
| +8% | +$560 | ﹤0.01% | 6929 |
|
|
2024
Q1 | $8.64K | Buy |
377
+302
| +403% | +$6.51K | ﹤0.01% | 6909 |
|
|
2023
Q4 | $1.32K | Buy |
75
+2
| +3% | +$29 | ﹤0.01% | 7167 |
|
|
2023
Q3 | $950 | Buy |
73
+6
| +9% | +$91 | ﹤0.01% | 7242 |
|
|
2023
Q2 | $1.12K | Hold |
67
| – | – | ﹤0.01% | 7228 |
|
|
2023
Q1 | $1.04K | Sell |
67
-9
| -12% | -$175 | ﹤0.01% | 7302 |
|
|
2022
Q4 | $1.27K | Sell |
76
-31
| -29% | -$558 | ﹤0.01% | 7306 |
|
|
2022
Q3 | $2K | Sell |
107
-5,044
| -98% | -$110K | ﹤0.01% | 7558 |
|
|
2022
Q2 | $113K | Sell |
5,151
-2,882
| -36% | -$70K | ﹤0.01% | 6408 |
|
|
2022
Q1 | $276K | Buy |
8,033
+7,752
| +2,759% | +$232K | ﹤0.01% | 6252 |
|
|
2021
Q4 | $12K | Buy |
281
+90
| +47% | +$5.83K | ﹤0.01% | 7654 |
|
|
2021
Q3 | $17K | Sell |
191
-2
| -1% | -$177 | ﹤0.01% | 7436 |
|
|
2021
Q2 | $14K | Sell |
193
-96
| -33% | -$4.46K | ﹤0.01% | 7230 |
|
|
2021
Q1 | $11K | Buy |
+289
| New | +$14.5K | ﹤0.01% | 6988 |
|
|
2020
Q4 | – | Sell |
-8
| Closed | – | – | 7116 |
|
|
2020
Q3 | $0 | Buy |
+8
| New | +$207 | ﹤0.01% | 6913 |
|
|
2019
Q4 | – | Sell |
-400
| Closed | -$4K | – | 7112 |
|
|
2019
Q3 | $4K | Sell |
400
-1,336
| -77% | -$19.2K | ﹤0.01% | 6882 |
|
|
2019
Q2 | $25K | Buy |
1,736
+1,359
| +360% | +$24.2K | ﹤0.01% | 6516 |
|
|
2019
Q1 | $7K | Sell |
377
-686
| -65% | -$13.6K | ﹤0.01% | 6731 |
|
|
2018
Q4 | $17K | Sell |
1,063
-75
| -7% | -$3.52K | ﹤0.01% | 6514 |
|
|
2018
Q3 | $105K | Buy |
1,138
+33
| +3% | +$3.92K | ﹤0.01% | 5847 |
|
|
2018
Q2 | $177K | Buy |
1,105
+996
| +914% | +$168K | ﹤0.01% | 5478 |
|
|
2018
Q1 | $17K | Sell |
109
-108
| -50% | -$13.2K | ﹤0.01% | 6433 |
|
|
2017
Q4 | $22K | Sell |
217
-255
| -54% | -$27.4K | ﹤0.01% | 6380 |
|
|
2017
Q3 | $61K | Buy |
472
+242
| +105% | +$29.6K | ﹤0.01% | 5858 |
|
|
2017
Q2 | $31K | Sell |
230
-31
| -12% | -$3.72K | ﹤0.01% | 6063 |
|
|
2017
Q1 | $31K | Buy |
261
+139
| +114% | +$16.4K | ﹤0.01% | 6122 |
|
|
2016
Q4 | $16K | Buy |
122
+102
| +510% | +$25.6K | ﹤0.01% | 6417 |
|
|
2016
Q3 | $5K | Buy |
+20
| New | +$2.45K | ﹤0.01% | 6601 |
|
Other funds holding CLSD
Bank of America's CLSD Position: Q4 2025 in Review
Bank of America sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 118 shares — an estimated $469 sold.
Bank of America first reported a position in CLSD in Q3 2016 and held it in 33 quarters. The position peaked at $276K in Q1 2022. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- Bank of America reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- Bank of America sold 118 Clearside Biomedical shares in Q4 2025, an estimated $469.
- Bank of America first reported a position in Clearside Biomedical in Q3 2016 and held it in 33 quarters.
- Bank of America's Clearside Biomedical position peaked at $276K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.